Comments from CFS, AVAAZ, and the STORM Coalition to Health Canada Pest Management Agency in support of the agency's proposal to prohibit the use of imidacloprid and encouraging the agency to expedite the proposed phase out process.
Invited Comments to the National Research Council Committee on “Future Biotechnology Products and Opportunities to Enhance the Capabilities of the Biotechnology Regulatory System.” By Doug Gurian-Sherman, Ph.D.
CFS Comments on the Food and Drug Administration’s Draft Environmental Assessment and Preliminary Finding of No Significant Impact for the Release of Genetically Engineered Mosquitoes as an Investigational New Animal Drug (Docket No. FDA-2014-N-2235)
ALL RIGHTS RESERVED. This material is protected under International and Federal Copyright Laws and Treaties. Any unauthorized reprint or use of this material is prohibited. No text may be reproduced or transmitted in any form or by any means without express written permission or proper citation. Please credit any and all use of our work product to: Center for Food Safety, www.centerforfoodsafety.org.